WATCHconviction 3published 2026-09-10

BLBD — Blue Bird Corporation · 2026-09-10 · Verdict: WATCH · Conviction 3

Price $62.59 (screen row, 2026-09-10) · Mkt cap $2.20B (fully diluted) · EV $2.20B · EV / normalised after-tax operating profit 14.4x forward, 15.4x trailing · FCF yield 7.0% · Net cash $1.1M · ADV $35.8M Sources read: 10-K filed 2025-11-24 for FY ended 2025-09-27 (Items 1, 1A, 7), 10-Q filed 2026-08-05 for Q3 FY26 ended 2026-06-27, DEF 14A 2026-01-26, 8-Ks 2026-04-02, 2026-05-04, 2026-05-06, 2026-05-18, 2026-08-05 (x2), Form 4s (12m). No transcript in the bundle.

Desk stats

1. What the business actually does

Blue Bird designs and assembles school buses in Fort Valley and Macon, Georgia, and since 1 April 2026 also Type A and small commercial buses through Micro Bird in Drummondville, Quebec and Plattsburgh, New York. It sells through 44 exclusive dealer locations (92.6% of FY25 units) plus direct fleet and government sales, and runs a small, very profitable Parts business (48% gross margin, $103M of FY25 sales). Its two Type C/D competitors, Thomas Built and IC Bus, are owned by Daimler and International (10-K Item 1A). Industry Type C/D volume has averaged about 30,500 units a year since 1985 and ran near 31,000 in 2025, so Blue Bird's 9,409 FY25 units is roughly 30% share, and management claims 64% of all alternative-powered school buses sold since fiscal 2015 (10-K Item 1).

2. Why it is mispriced — the edge case

There is none, which caps this at WATCH. ADV is $35.8M, BlackRock owns 7.6% and Vanguard 6.0% (DEF 14A, as at 2026-01-15), and the old American Securities control block was sold down in the 2023-24 secondaries (10-K Item 7). The stock is 23.2% off its 52-week high but up 17.2% in six months with positive twelve-month momentum, so it is not a broken security. The one structural quirk cuts against the buyer: the 2,702,180 exchangeable shares, 7.9% of the diluted count, begin unlocking on 2026-10-01 (17.9%, about 484,000 shares) and then in tranches to April 2029, with Blue Bird obliged to register the resale (8-K 2026-04-02). That is supply arriving in three weeks, not a forced seller handing you a discount.

3. Unit economics and growth

The margin record is genuinely good: Adjusted EBITDA went $87.9M (7.8%) in FY23 to $182.9M (13.6%) in FY24 to $221.3M (15.0%) in FY25, guided to ~$247M on ~$1.75B for FY26 (10-K Item 7; 8-K 2026-08-05). ROIC on normalised operating profit is above 20% and capex is light, FY25 $22.9M against $17.2M of D&A. But the composition has changed. Q3 Adjusted EBITDA margin fell to 13.8% from 14.7%, because Micro Bird earns a 14.1% gross margin against legacy Bus at 20.0% and because legacy Q3 gross profit rose only $0.2M; of the $12.6M increase in Q3 operating profit, $11.4M was Micro Bird (10-Q MD&A). Pricing power is real but is tariff pass-through rather than mix improvement: management says the increases "were intended to mitigate" higher import costs. Type C/D backlog is 3,570 units, down from 3,900 a year earlier though up from the 3,070 September trough, plus 1,290 Type A and commercial units and almost 780 electric across all types (10-Q MD&A). Nine-month free cash flow was $92.7M against $92.9M, flat, and included a one-off $29.4M customer advance.

4. Balance sheet and capital allocation

Clean. $116.8M cash, $86.8M of term debt, $28.9M of finance leases, revolver undrawn. The frozen pension plan was terminated in May 2026 and settled entirely out of plan assets with no company contribution, producing a $19.6M non-cash charge and removing the liability for good (8-K 2026-05-18). Share count is roughly flat: $39.5M repurchased in FY25 and $19.9M in nine months of FY26 against the 2.70M shares issued for Micro Bird, with about $90M of authorisation left to January 2028. Insider activity is thin and slightly negative: one director bought 650 shares for $42,056 at $65.09 and $64.37, against $543,286 of sales including the CFO at $60.98 (Form 4s, 2026-02-20 to 2026-08-13). Pay is 70% weighted to Adjusted EBITDA, and the FY25 target was set at $180M, below FY24's actual $182.9M, with maximum near $220M; actual $221.3M paid 200% of target (DEF 14A). That is a soft bar.

5. Management: what they said vs what they did

They have delivered and then raised: FY26 Adjusted EBITDA guidance went to ~$245M on 2026-05-06 and ~$247M on 2026-08-05, both beats. The concern is the long-term number. On 2026-05-06 the 2030+ target was "$375+ million, or 15%+, on $2.5+ billion in revenue"; thirteen weeks later it was "$500+ million, or 15%+, on $3.3 billion." The increment rests on the Ford Master Collaboration Agreement and a $7.0M asset purchase from Detroit Chassis: prototypes targeted for 1 January 2028, production in the first half of calendar 2028, "upfront investment and manufacturing costs borne by BBBC," and a possible 10,000 units and "$600 million or more" of annual revenue (8-K 2026-08-05). Adding $800M of 2030 revenue on a program that has not built a prototype is a promise, not a plan.

6. Valuation

Base: FY27 revenue ~$2.0B on a full year of Micro Bird and low single digit legacy price growth, Adjusted EBITDA ~$270M at 13.5%, after-tax operating profit ~$165M, 14x, $66. Bear: the post-COVID replacement bulge normalises, units fall 10% and the tariff surcharge is competed away; Adjusted EBITDA $180M, after-tax $98M, 11x, $31. Bull: Ford F-53/F-59 delivers 10,000 units at a 10% margin by FY2029 on top of $290M from buses, Adjusted EBITDA $350M, after-tax $225M, 15x, $96. Weighting 50/30/20 gives $61.50, about 2% below the $62.59 price. Reverse DCF: at a 10% cost of capital the price implies about 3% perpetual growth in normalised after-tax operating profit, 4% at 11% — not an aggressive hurdle, and not a discount either.

7. Catalysts and timeline

Q4 FY26 and the first FY2027 guide, late November 2026: the largest quarter, and the one that must convert the finished-goods build that pushed Q3 legacy units down 7.2%. First exchangeable-share unlock 2026-10-01. Detroit Chassis closing in Q1 CY2027. Resolution of the $80M DOE MESC grant, under review since early 2025 against a $160M project Blue Bird says it will fund more of itself (10-K Item 1).

8. Kill criteria (pre-registered)

  1. Consolidated Adjusted EBITDA margin below 13.0% for two consecutive quarters.
  2. Type C/D backlog below 3,000 units at any reporting date.
  3. Legacy Blue Bird unit bookings down more than 5% year over year in FY2027 Q1 and Q2 together.
  4. Insider net open-market selling above $2M in any rolling six months, or Ford-program capex guided above $150M before any revenue.

9. Verdict and summary

WATCH, conviction 3. Blue Bird is a good business at a fair price with no mispricing to exploit. It is the only independent of the three Type C/D school bus makers, it has taken Adjusted EBITDA margin from 7.8% to 15.0% in three years, it is debt-free after buying in the other half of Micro Bird for $201.8M, and it just terminated its pension plan without spending a dollar of company cash. But the screen's cheapness is an accident of compensating errors: count the 2.70M exchangeable shares and the finance leases and you pay 14.4x forward normalised after-tax operating profit, a price already implying about 3% perpetual growth. Under the acquisition headline the legacy business is not growing, with nine-month legacy revenue up 0.9% on price alone, units down 4.6%, legacy Adjusted EBITDA up 1.5%, Type C/D backlog 8% below a year ago and Q3 margin down 90 basis points. The 2030 target was raised from $375M to $500M of EBITDA in thirteen weeks on a Ford chassis program that will not build a prototype until 2028 and whose upfront cost Blue Bird bears. Nothing forces anyone to sell, one director has bought $42,000, and the first tranche of locked-up stock releases on 1 October. Wait for the late-November Q4 print and first FY2027 guide, which show whether the deferred Q3 units converted, what a full year of Micro Bird earns, and what Ford costs before it earns anything.

Research for discussion, not investment advice. Positions and sizing are the reader's decision.

Source markdown: 2026-09-10_BLBD.md · how these notes are built · every verdict tracked since publication.

Research and education only. Nothing here is investment advice or a recommendation to buy or sell any security. No price targets are recommendations; positions and sizing are the reader's decision. Past performance does not predict future results.